🇨🇾

Cyprus for Biotech / Life Sciences

europeWorldwideBIOTECH / LIFE SCIENCES
81
Overall
65
BIOTECH
Industry Rank
#7of 27
Key Strength
Family
Tax Regime
Worldwide
Verdict
Best For

Founders relocating with family - Cyprus scores 100/100 on cost of living, safety, and international schooling.

Not Ideal For

Fully remote teams without local presence - Cyprus's remote infrastructure score (64/100) presents some limitations.

Bottom Line

Ranked #7 of 27 jurisdictions for Biotech / Life Sciences. The Biotech / Life Sciences weighting reduces Cyprus's score by 16 points from its overall score of 81/100 - general strengths don't fully translate to this specific industry.

BIOTECH / LIFE SCIENCES-WEIGHTED DIMENSION PROFILE

Muted: default profile / Blue: industry-weighted

Strengths
Family100

Strong family environment for biotech / life sciences operators.

Visa90

Strong visa environment for biotech / life sciences operators.

Practical86

Strong practical environment for biotech / life sciences operators.

Watch Outs
Remote64

Lower remote score - verify current requirements carefully.

Residency65

Lower residency score - verify current requirements carefully.

Ecosystem65

Lower ecosystem score - verify current requirements carefully.

Key Metrics for Biotech / Life Sciences
12.5%
Corporate Tax
20
Active VCs
$95M
VC Deployed
Yes
Gov Grants
Yes
EU Funding
60
Talent Pool
Yes
IP Box Regime
5
Incorporation

Why Cyprus Works for Biotech / Life Sciences

Family viability (100/100) is a genuine strength for Cyprus - important for Biotech / Life Sciences founders relocating with a partner or children. The cost of living index is 70 (NYC = 100), with a comfortable family monthly budget of $6K. Safety scores 80/100. International schools are available, and healthcare quality scores 75/100 with private insurance running approximately $300/month.

Operational ease (86/100) makes Cyprus practical for Biotech / Life Sciences founders setting up from scratch. Banking difficulty for foreigners is rated moderate. Company formation takes approximately 5 days at a cost of around $2K, with annual compliance costs around $3K. Full foreign ownership is permitted - no local partner required. IP protection quality is rated moderate, which matters for Biotech / Life Sciences businesses with proprietary technology or brand assets.

Funding access (85/100) is a standout for Cyprus Biotech / Life Sciences companies. The local market has 20 active VC funds, with average seed checks of $350K. Government grant programs include RESTART 2016-2020 (Research Promotion Foundation) ($200K) and Horizon Europe (EIC) ($2.5M). Non-dilutive capital availability reduces the pressure to give up equity at early stage, which is particularly valuable for capital-efficient Biotech / Life Sciences businesses.

Watch Outs for Biotech / Life Sciences Founders in Cyprus

Remote infrastructure (64/100): Cyprus presents some limitations for fully remote teams. Connectivity, coworking density, or legal clarity for remote work may require additional planning for distributed Biotech / Life Sciences operations.

Residency access (65/100): Visa and residency options for non-citizens are more limited or complex than in purpose-built founder-friendly jurisdictions. Founders who need a fast, reliable residency pathway should verify program eligibility requirements before choosing Cyprus as a base.

Ecosystem depth (65/100): The local startup ecosystem is less developed than leading hubs. Biotech / Life Sciences founders who depend on domain-specific mentors, accelerators, or local angel networks may find the community thinner than in Europe or Singapore. Remote-first operations and access to global networks can compensate, but this is a real consideration for companies that benefit from in-person founder density.

Setup Requirements for Biotech / Life Sciences in Cyprus
  1. Entity type: 100% foreign-owned company permitted - no local partner required
  2. Banking: moderate access for foreign founders. Common options include Bank of Cyprus, Hellenic Bank, Eurobank Cyprus.
  3. Formation: approximately 5 days to incorporate, estimated cost $2K plus annual compliance of $3K
  4. Licensing: Regulator - MMDA / EMA
  5. Timeline: 60 days visa processing + 5 days formation = approximately 65 days to be fully operational
  6. Visa pathway: Cyprus Startup Visa (minimum investment $33K, 24-month initial permit)
Industry Key Facts
MMDA / EMA
Regulator
Very limited (1.2M population)
Trial Scale
2.5% on patent income
Pharma IP Box
IP holding for pharma
Use Case
Compare Cyprus vs Top Alternatives for Biotech / Life Sciences
🇨🇾Cyprus
65
🇲🇹Malta
61

Biotech / Life Sciences industry scores

🇨🇾Cyprus
65
🇮🇪Ireland
52

Biotech / Life Sciences industry scores

🇨🇾Cyprus
65
🇬🇪Georgia
49

Biotech / Life Sciences industry scores

Top Biotech / Life Sciences Jurisdictions
Frequently Asked Questions
Is Cyprus good for Biotech / Life Sciences in 2026?

Cyprus ranks #7 of 27 jurisdictions for Biotech / Life Sciences on NomadSignal's scoring model, with an industry-weighted score of 65/100. The top strengths for Biotech / Life Sciences founders are family viability and operational ease. Whether it is the right choice depends on your funding stage, personal tax situation, and whether you are relocating alone or with a family.

What is the corporate tax rate in Cyprus?

Cyprus applies a statutory corporate tax rate of 12.5%, and an IP box regime at 2.5% for qualifying IP income. The jurisdiction has 65 active tax treaties. For Biotech / Life Sciences founders, corporate tax efficiency carries a 8% weight in the industry scoring model. Verify the current effective rate with a local advisor before making an incorporation decision.

Does Cyprus have Biotech / Life Sciences-specific programs or incentives?

Cyprus accesses EMA through EU membership via the Cyprus Medicines and Medical Devices Agency. Small patient population limits trial scale. IP Box extends to pharmaceutical patents at 2.5% effective rate. Used as an IP holding jurisdiction for pharma more than as an operational base. Cyprus offers a startup or entrepreneur visa pathway for qualifying founders. NomadSignal evaluates Biotech / Life Sciences-specific factors including Regulatory Approval Pathway, Clinical Trial Environment, Patent Regime for Biologics as part of the industry score. Check the country's official government and innovation agency websites for current program details.

How does Cyprus compare to other jurisdictions for Biotech / Life Sciences?

Cyprus ranks #7 for Biotech / Life Sciences with 65/100. The #1 ranked jurisdiction is Singapore at 73/100. The gap is driven mainly by remote infrastructure, where Cyprus is weaker. Use NomadSignal's comparison pages to evaluate Cyprus head-to-head against specific alternatives.

Discussion (0)

A community of sovereign individuals - founders, families, and remote operators. Share what you know, ask what you don't.

No comments yet - be the first to share what you know about this page.

Data as of March 2026. Not legal, tax, or immigration advice.